학술논문

The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta‐analysis
Document Type
article
Source
Clinical and Translational Science, Vol 17, Iss 4, Pp n/a-n/a (2024)
Subject
Therapeutics. Pharmacology
RM1-950
Public aspects of medicine
RA1-1270
Language
English
ISSN
1752-8062
1752-8054
Abstract
Abstract The aggregated risk of recurrent stroke in stroke/transient ischemic attack (TIA) patients carrying CYP2C19 LoF alleles who take clopidogrel has not been investigated recently, and the available research is limited. This study aimed to perform an updated meta‐analysis to assess the association between CYP2C19 LoF alleles and the risk of recurrent stroke in patients taking clopidogrel. Databases were searched for the literature on eligible studies. The end points were recurrent stroke, composite vascular events, and bleeding events. Odds ratios (ORs) were calculated using RevMan software, where p